title: Recent changes in practice guidelines for atrial fibrillation management.
authors.affiliation: Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy at University of the Sciences, Philadelphia, Pennsylvania.
authors.forename: Lisa
authors.initials: L
authors.lastname: Charneski
authors.forename: James M
authors.initials: JM
authors.lastname: Hollands
mesh_terms: D000367:Age Factors; D000572:American Heart Association; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D002309:Cardiology / Q000639:trends; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D012955:Societies, Medical; D020521:Stroke / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D014481:United States; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D014812:Vitamin K
keywords: anticoagulation; arrhythmia; atrial fibrillation; guidelines; stroke